Ministry of Chemicals and Fertilizers
Government
Open

PLI Scheme for Bulk Drugs — 5%–20% Incentives on KSM, DI & API Sales — Eligibility Criteria

Eligibility

PLI Scheme for Bulk Drugs — 5%–20% Incentives on KSM, DI & API Sales is open to startups registered in India. The full eligibility criteria — qualifying sectors, states and entity types — are below.

Who can apply

Who can apply

  • Manufacturers of critical KSMs, DIs and APIs that are registered in India.
  • The project must be greenfield — a new manufacturing facility built from the ground up. Extending or upgrading an existing plant does not qualify.
  • Applicants must commit a threshold investment that varies by product segment, ranging from ₹20 crore to ₹400 crore.

Beyond these points, eligibility rests on the product being manufactured, the greenfield nature of the facility and the investment committed.

PLI Scheme for Bulk Drugs — 5%–20% Incentives on KSM, DI & API Sales is open to startups at any stage working in health lifesciences. It is open to startups registered anywhere in India. Applicants should be registered as private limited, llp and opc.

health lifesciences
Eligible stage
Any stage
Location
Open to startups registered in India
Entity type
Private Limited, Llp, Opc, Partnership, Proprietorship

← Back to PLI Scheme for Bulk Drugs — 5%–20% Incentives on KSM, DI & API Sales overview